NIH-supported study shows this treatment resulted in higher rates of illicit opioid abstinence than current standard of care.

Patients who are prescribed higher daily doses of the medication buprenorphine for opioid use disorder are significantly more ...

Weekly injectable buprenorphine is more effective than daily doses for treating opioid use disorder in pregnancy, with higher ...

The practitioners at Best Care Family and Wellness Centers see the value in providing primary care and addiction services under one roof. We have seen this approach change the lives of many patients ...

Please provide your email address to receive an email when new articles are posted on . Buprenorphine treatment in the ED was associated with almost two times greater odds of 30-day OUD treatment. The ...

Weekly injections led to higher opioid abstinence rate, with good infant outcomes ...

In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly ...

Patients adherent to SUBLOCADE® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients ...

Please provide your email address to receive an email when new articles are posted on . Approximately 22% of addiction treatment facilities require adolescents be off buprenorphine prior to admission.

After someone lives through an opioid overdose, taking the medication buprenorphine lowers their risk of death if they OD again, a new study found. Buprenorphine is a medication used to treat opioid ...

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...

Signing into law a change that can prevent thousands of Americans from dying of opioid overdoses should have been met with fanfare. Instead, it not only slid under the media radar but hasn’t been ...